Companies / South Korea
FTA Boosts Pharmaceutical Market
April 2007 | Trade AlertBMI has increased the growth trajectory of the South Korean pharmaceutical market after the country signed a long-awaited free trade agreement (FTA) with the US. No significant difference is expected in 2007, because the deal has yet to be implemented by the two nations and it will take some time before the new rules translate into increased sales. But from 2008, we project a 0.5% increase in year-on-year growth through to 2011, when BMI forecasts the value of the pharmaceutical market to be US$21.57bn, up from our previous projection of
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
